Northbrook, IL, United States of America

Jonathan D Licht

This inventor holds 2 USPTO granted patents. Top assignees: Albert Einstein College of Medicine, Icahn School of Medicine at Mount Sinai, Other. Active years: 2011-2014.


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Jonathan D Licht

Introduction

Jonathan D Licht is a notable inventor based in Northbrook, IL (US). He has made significant contributions to the field of cancer research through his innovative patents. With a total of 2 patents, Licht's work focuses on methods and compositions that target BCL6 repression, which is crucial in cancer treatment.

Latest Patents

Licht's latest patents include methods and compositions for the inhibition of BCL6 repression. These patents provide peptides or mimetics that block corepressor binding to a BCL6 lateral groove. Additionally, they outline methods for inhibiting BCL6 repression in mammalian cells and offer approaches for treating mammals with cancer. This innovative work has the potential to advance therapeutic strategies in oncology.

Career Highlights

Throughout his career, Jonathan D Licht has been associated with prestigious institutions such as the Albert Einstein College of Medicine and the Icahn School of Medicine at Mount Sinai. His work in these organizations has allowed him to collaborate with leading experts in the field, further enhancing his contributions to medical science.

Collaborations

Some of Licht's notable coworkers include Gilbert Privé and Ari Matthew Melnick. Their collaborative efforts have likely played a role in the development of his innovative patents and research initiatives.

Conclusion

Jonathan D Licht's contributions to cancer research through his patents demonstrate his commitment to advancing medical science. His innovative methods for inhibiting BCL6 repression hold promise for future cancer treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…